by the fact that other winners this year are the co-founders of BioNTech for their invention of the (Pfizer

examples of impacts from cryo-EM in therapeutics design, focusing largely on its implementation at Pfizer

Sosei Heptares' Partner Pfizer Progresses its Oral GLP-1 Receptor Agonist PF-07081532 into Phase 2 Clinical

BenevolentAI, Exscientia on the comeback trail after securing separate AI drug discovery deals with Merck KGaA Pfizer

Out-Licensing Agreement with Bridge Biotherapeutics in Idiopathic Pulmonary Fibrosis Former execs from Pfizer

Award for GPCR Research Bryan Roth, Natural Products, and the John Daly Legacy Sosei Heptares’ Partner, Pfizer